Fatigue after prophylactic cranial irradiation in small cell lung cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26234

Enrollment

Registered

2013-10-21

Start date

2013-11-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatigue, small cell lung cancer (SCLC), PCI vermoeidheid, kleincellig longcarcinoom, profylactische schedelbestraling

Interventions

questionnaires: regarding fatigue: VAS and MVI-20 regarding quality of life: EORTCc30 and EuroQol 5D

Eligibility

Inclusion criteria

Inclusion criteria: -Age >=18 years -SCLC, pathology proven -Completed initial treatment, with at least stable disease -WHO PS ¡Ü 2 -Ability to understand written questionnaires -Written informed consent

Exclusion criteria

Exclusion criteria: - clinically relevant anemia (defined as Hb < 6 mmol/l) - chronic renal failure (defined as MDRD-eGFR < 45 ml/min/1.73m) - liver biochemistry abnormalities (defined as more than two times upper limit of normal) - major psychiatric illness requiring intervention in secondary care

Design outcomes

Primary

Measure	Time frame
Onset and level of fatigue after PCI measured by VAS	—

Secondary

Measure	Time frame
Onset and level of fatigue after PCI measured by additional questionnaire: MVI-20 Changes in quality of life (Qol) after PCI: EORTC c30 and EuroQol-5D	—

Contacts

Public ContactL. Hendriks

Dept of Pulmonary Diseases, MUMC+ PO Box 5800

lizza.hendriks@mumc.nl+31 (0) 43 387 6543

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)